Citigroup
CCM

Citigroup’s Concord Medical Services CCM Stock Holding History

Citigroup’s Portfolio CCM Stock Details CCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-20
Closed -$328 – 5531
2022
Q4 		$328 Sell
20
-2
-9% -$31 ﹤0.01% 5555
2022
Q3 		$0 Hold
22
– – ﹤0.01% 5865
2022
Q2 		$0 Buy
+22
New +$370 ﹤0.01% 6265
2015
Q3 		– Sell
-6
Closed – – 7388
2015
Q2 		$0 Buy
+6
New +$418 ﹤0.01% 7531
2014
Q1 		– Hold
0
– – – 7017
2013
Q4 		– Hold
0
– – – 6984
2013
Q3 		– Sell
-305
Closed -$11K – 6801
2013
Q2 		$11K Buy
+305
New +$11.2K ﹤0.01% 6055

Other funds holding CCM

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup's CCM Position: Q1 2023 in Review

Citigroup sold out of Concord Medical Services (CCM) in Q1 2023, closing a stake of 20 shares — an estimated $328 sold.

Citigroup first reported a position in CCM in Q2 2013 and held it in 5 quarters. The position peaked at $11K in Q2 2013. 3 funds tracked by Wall St. Rank hold CCM as of Q1 2023.

  • Citigroup reported no remaining Concord Medical Services position as of Q1 2023 after selling out during the quarter.
  • Citigroup sold 20 Concord Medical Services shares in Q1 2023, an estimated $328.
  • Citigroup first reported a position in Concord Medical Services in Q2 2013 and held it in 5 quarters.
  • Citigroup's Concord Medical Services position peaked at $11K in Q2 2013.
  • 3 funds tracked by Wall St. Rank held Concord Medical Services as of Q1 2023.

Based on Citigroup's 13F filing for Q1 2023, filed 11 May 2023.